TBPH and ZYME Related Headlines
Go Back- H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral
- BTIG Downgrades Theravance Biopharma (TBPH) to Neutral
- Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
- Zymeworks to buy Theravance Biopharma for $17 per share
- Zymeworks to Acquire Theravance Biopharma, Inc.

